<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Subst Abuse Treat</journal-id><journal-id journal-id-type="iso-abbrev">J Subst Abuse Treat</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of substance abuse treatment</journal-title></journal-title-group><issn pub-type="ppub">0740-5472</issn><issn pub-type="epub">1873-6483</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10084712</article-id><article-id pub-id-type="pmcid-ver">PMC10084712.1</article-id><article-id pub-id-type="pmcaid">10084712</article-id><article-id pub-id-type="pmcaiid">10084712</article-id><article-id pub-id-type="manuscript-id">NIHMS1880889</article-id><article-id pub-id-type="pmid">36084559</article-id><article-id pub-id-type="doi">10.1016/j.jsat.2022.108870</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1880889</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1880889</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>DAVID</surname><given-names initials="AR">Allison R.</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>SIAN</surname><given-names initials="CR">Carlos R.</given-names></name><degrees>MPH</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>GEBEL</surname><given-names initials="CM">Christina M.</given-names></name><degrees>MPH</degrees><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>LINAS</surname><given-names initials="BP">Benjamin P.</given-names></name><degrees>MD, MPH</degrees><xref rid="A2" ref-type="aff">b</xref><xref rid="A3" ref-type="aff">c</xref><xref rid="A4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>SAMET</surname><given-names initials="JH">Jeffrey H.</given-names></name><degrees>MD, MA, MPH</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>SPRAGUE MARTINEZ</surname><given-names initials="LS">Linda S.</given-names></name><degrees>PhD</degrees><xref rid="A5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>MUROFF</surname><given-names initials="J">Jordana</given-names></name><degrees>PhD</degrees><xref rid="A5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>BERNSTEIN</surname><given-names initials="JA">Judith A.</given-names></name><degrees>PhD</degrees><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>ASSOUMOU</surname><given-names initials="SA">Sabrina A.</given-names></name><degrees>MD, MPH</degrees><xref rid="A2" ref-type="aff">b</xref><xref rid="A4" ref-type="aff">d</xref></contrib></contrib-group><aff id="A1"><label>a.</label>Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston, MA, USA</aff><aff id="A2"><label>b.</label>Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, MA, USA</aff><aff id="A3"><label>c.</label>Department of Community Health Sciences, Boston University School of Public Health, Boston, MA, USA</aff><aff id="A4"><label>d.</label>Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA</aff><aff id="A5"><label>e.</label>Boston University School of Social Work, Boston, MA, USA</aff><author-notes><corresp id="CR1">Corresponding author Sabrina A. Assoumou, MD, MPH, Louis W. Sullivan, MD, Endowed Professor of Medicine, Assistant Professor, Department of Medicine, Section of Infectious Diseases, Boston University School of Medicine, Boston Medical Center, 801 Massachusetts Ave., Crosstown Center, 2<sup>nd</sup> Floor, Boston, MA 02118, P: 617-414-2896, F: 617-414-3534, <email>sabrina.assoumou@bmc.org</email></corresp><fn fn-type="con" id="FN1"><p id="P1">Author statement</p><p id="P2">Conceptualization: Assoumou, Bernstein</p><p id="P3">Data curation: Assoumou, Bernstein, Sian</p><p id="P4">Formal analysis: David, Assoumou, Bernstein, Sian, Gebel,</p><p id="P5">Funding acquisition: Assoumou</p><p id="P6">Methodology: Assoumou, Bernstein, Gebel</p><p id="P7">Project administration: Assoumou, Sian</p><p id="P8">Resources: Assoumou</p><p id="P9">Software: Assoumou, Gebel</p><p id="P10">Supervision: Assoumou, Bernstein</p><p id="P11">Validation: David, Assoumou, Bernstein, Gebel, Sian</p><p id="P12">Roles/Writing - original draft: David, Assoumou, Bernstein</p><p id="P13">Writing - review &amp; editing: David, Assoumou, Bernstein, Gebel, Linas, Sian, Samet, Sprague Martinez, Muroff</p></fn><fn id="FN2"><p id="P14">Allison R. David, MD, Department of Medicine, Boston Medical Center, 72 East Concord Street, Evans 124, Boston, MA 02118, <email>Allison.david@bmc.org</email></p><p id="P15">Carlos R. Sian, MPH, Section of Infectious Diseases, Boston Medical Center, 801 Massachusetts Ave., Crosstown Center, 2nd Floor, Boston, MA 02118, <email>csian@bu.edu</email></p><p id="P16">Christina M. Gebel, MPH, Boston University School of Public Health, <email>cgebel@gmail.com</email></p><p id="P17">Benjamin P. Linas, MD, MPH, Professor of Medicine, Boston University School of Medicine, Professor of Epidemiology, Boston University School of Public Health, 801 Massachusetts Ave., Crosstown Center, 2<sup>nd</sup> Floor, Boston, MA 02118, P: 617-414-5238, F:617-414-3534, <email>Benjamin.Linas@bmc.org</email></p><p id="P18">Jeffrey H. Samet, MD, MA, MPH, John Noble, MD Professor of Medicine and Professor of Community Health Sciences, Boston University Schools of Medicine and Public Health, Vice Chair for Public Health, Department of Medicine, 801 Massachusetts Avenue, 2nd Floor, Boston, MA 02118, P: 617-414-7288, F: 617-414-4676, <email>jsamet@bu.edu</email></p><p id="P19">Linda S. Sprague Martinez, PhD, Associate Professor, Boston University School of Social Work, 264 Bay State Road, Boston, MA 02215, P:617-358-0782, <email>lsmarti@bu.edu</email></p><p id="P20">Jordana Muroff, PhD, Associate Professor and Chair, Clinical Practice Department, Boston University School of Social Work, <email>jmuroff@bu.edu</email></p><p id="P21">Judith A. Bernstein, PhD, Emerita Professor, Boston University School of Public Health, Dept of Community Health Sciences, 801 Massachusetts Ave, Crosstown Center, Boston, MA 02118, P: 617-414-1415, <email>jbernste@bu.edu</email></p></fn><fn fn-type="COI-statement" id="FN3"><p id="P92"><bold>Conflict of interest:</bold> The authors have no conflicts of interest to declare. Linda Sprague Martinez is an external evaluator for the Boston Public Health Commission and Action for Boston Area Development and a research consultant for BMC and The City School.</p></fn></author-notes><pub-date pub-type="ppub"><month>11</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>01</day><month>9</month><year>2022</year></pub-date><volume>142</volume><issue-id pub-id-type="pmc-issue-id">433109</issue-id><fpage>108870</fpage><lpage>108870</lpage><pub-history><event event-type="nihms-submitted"><date><day>17</day><month>03</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>11</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>01</day><month>11</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-16 18:25:15.313"><day>16</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1880889.pdf"/><abstract id="ABS1"><sec id="S1"><title>Introduction:</title><p id="P22">Access to and uptake of evidence-based treatment for substance use disorder, specifically opioid use disorder (OUD), are limited despite the high death toll from drug overdose in the United States in recent years. Patient perceived barriers to evidence-based treatment after completion of short-term inpatient medically managed withdrawal programs (detox) have not been well studied. The purpose of the current study is to elicit patients&#8217; perspectives on challenges to transition to treatment, including medications for OUD (MOUD), after detox and potential solutions.</p></sec><sec id="S2"><title>Methods:</title><p id="P23">We conducted semi-structured interviews (N=24) at a detox center (2018&#8211;2019) to explore patients&#8217; perspectives on obstacles to treatment. The study managed the data in NVivo and we used content analysis to identify themes.</p></sec><sec id="S3"><title>Results:</title><p id="P24">Patients&#8217; characteristics included the following: 54% male; mean age 37 years; self-identified as White 67%, Black 13%, Latinx 8%, Native Hawaiian/Pacific Islander 4%, and other 8%; heroin use in the past 3 months 67%; and ever injecting drugs 71%. Patients identified the following barriers: 1) lack of continuity of care; 2) limited number of detox and residential treatment program beds; 3) unstable housing; and 4) lack of options when choosing a treatment pathway. Solutions proposed by participants included: 1) increase low-barrier access to community MOUD; 2) add case managers at the detox center to establish continuity of care after discharge; 3) increase assistance with housing; and 4) encourage patient participation in treatment decisions.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P25">Patients identified lack of continuity of care, especially care coordination, as a major barrier to substance use treatment. Increasing treatment utilization, including MOUD, necessitates a multimodal approach to continuity of care, low-barrier access to MOUD, and support to address unstable housing. Patients want care that incorporates options and respect for individualized preferences and needs.</p></sec></abstract><kwd-group><kwd>Drug detoxification center</kwd><kwd>People who inject drugs</kwd><kwd>Continuity of care</kwd><kwd>Linkage to care</kwd><kwd>Access to care</kwd><kwd>Medications for opioid use disorder</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>